Display Settings:

Format

Send to:

Choose Destination

    FEBS Lett. 2000 Jan 14;465(2-3):124-8.

    Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines.

    Mori T, Okamoto H, Takahashi N, Ueda R, Okamoto T.

    Department of Molecular Genetics, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan.

    The p53-binding protein 2 (53BP2) was identified as a binding protein to a tumor suppressor p53. We examined the genetic aberrations of 53BP2 gene in various human cancer cell lines. Although no gross genomic alteration or mutation of 53BP2 gene was observed, 53BP2 mRNA levels were highly variable. There was no association between the 53BP2 mRNA level and the p53 status. When we examined sensitivities of these cell lines to DNA-damaging agents including UV irradiation, X-ray irradiation and cis-diamine-dichloroplatinum (CDDP), we found that higher 53BP2 mRNA expression was correlated with the sensitivity to these agents.

    PMID: 10631318 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Cisplatin (Platinol®-AQ)

      Your doctor has ordered the drug cisplatin to help treat your illness. The drug is given by injection into a vein.